A PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF AN ORAL BRANCHED-CHAIN KETOACID DEHYDROGENASE KINASE INHIBITOR, PF-07328948, IN ADULTS WITH HEART FAILURE (BRANCH-HF)
Latest Information Update: 02 Jun 2025
At a glance
- Drugs PF 07328948 (Primary)
- Indications Heart failure
- Focus Adverse reactions; Therapeutic Use
- Acronyms BRANCH-HF
- Sponsors Pfizer
Most Recent Events
- 02 Jun 2025 New trial record